Literature DB >> 19514510

[Acute eosinophilic pneumonia caused by several drugs including ibuprofen].

Eiichiro Anan1, Ryo Shirai, Naoko Kai, Hiroshi Ishii, Norio Hirata, Kenji Kishi, Issei Tokimatsu, Kaoru Nakama, Kazufumi Hiramatsu, Jun-Ichi Kadota.   

Abstract

A 41-year-old woman took an EVE-A tablet, which contained ibuprofen, because of pyrexia over 39 degrees C. Due to continued pyrexia, she visited a physician and received cefcapene and acetaminophen under a diagnosis of cold. However, next day, she was admitted to our hospital with severe hypoxemia and pulmonary infiltrates on chest radiograph. Analysis of bronchoalveolar lavage fluid disclosed an increased proportion of 66% eosinophils. All of the lymphocyte stimulation tests for EVE-A tablet, cefcapene and acetaminophen showed positive. After the cessation of these drugs, she was successfully treated with steroids. This case was diagnosed as eosinophilic pneumonia caused by several drugs, and to our knowledge, this is the first report in Japan of ibuprofen (EVE-A tablet)-induced pneumonia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19514510

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  4 in total

Review 1.  Drug-induced eosinophilic pneumonia: A review of 196 case reports.

Authors:  Carmi Bartal; Iftach Sagy; Leonid Barski
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

2.  Drug-induced lung injury caused by acetaminophen in a Japanese woman: A case report.

Authors:  Masayoshi Fujii; Tsuneaki Kenzaka
Journal:  World J Clin Cases       Date:  2022-09-26       Impact factor: 1.534

3.  Minocycline-induced acute eosinophilic pneumonia: A case report and review of the literature.

Authors:  Sharon W Hung
Journal:  Respir Med Case Rep       Date:  2015-05-30

4.  Vaping Is Not Safe: A Case of Acute Eosinophilic Pneumonia following Cannabis Vapor Inhalation.

Authors:  Daniel Antwi-Amoabeng; Raheel Islam
Journal:  Case Rep Pulmonol       Date:  2020-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.